Market News Archive
Stay updated with the latest announcements
SIMTEX: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2024 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
GLDNJMF: Weekly NAV
On the close of operation on 05-Nov-2024, the Fund has reported Net Asset Value (NAV) of Tk. 8.95 per unit on the basis of current market price and Tk. 10.44 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 895,270,477.63 on the basis of current market price and Tk. 1,043,895,507.35 on the basis of cost price after considering all assets and liabilities of the Fund.
ICBAGRANI1: Weekly NAV
On the close of operation on 05-Nov-2024, the Fund has reported Net Asset Value (NAV) of Tk. 9.15 per unit on the basis of current market price and Tk. 11.60 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 897,868,625.27 on the basis of current market price and Tk. 1,138,807,415.99 on the basis of cost price after considering all assets and liabilities of the Fund.
ICBSONALI1: Weekly NAV
On the close of operation on 05-Nov-2024, the Fund has reported Net Asset Value (NAV) of Tk. 8.55 per unit on the basis of current market price and Tk. 12.14 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 854,559,257.86 on the basis of current market price and Tk. 1,213,845,846.21 on the basis of cost price after considering all assets and liabilities of the Fund.
IFILISLMF1: Weekly NAV
On the close of operation on 05-Nov-2024, the Fund has reported Net Asset Value (NAV) of Tk. 7.01 per unit on the basis of current market price and Tk. 11.54 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 701,446,887,56 on the basis of current market price and Tk. 1,153,574,224.21 on the basis of cost price after considering all assets and liabilities of the Fund.
PF1STMF: Weekly NAV
On the close of operation on 05-Nov-2024, the Fund has reported Net Asset Value (NAV) of Tk. 7.35 per unit on the basis of current market price and Tk. 12.70 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 441,113,520.14 on the basis of current market price and Tk. 761,946,441.31 on the basis of cost price after considering all assets and liabilities of the Fund.
ICB3RDNRB: Weekly NAV
On the close of operation on 05-Nov-2024, the Fund has reported Net Asset Value (NAV) of Tk. 7.55 per unit on the basis of current market price and Tk. 12.20 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 755,345,536.87 on the basis of current market price and Tk. 1,219,501,631.31 on the basis of cost price after considering all assets and liabilities of the Fund.
PRIME1ICBA: Weekly NAV
On the close of operation on 05-Nov-2024, the Fund has reported Net Asset Value (NAV) of Tk. 7.96 per unit on the basis of current market price and Tk. 12.57 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 795,891,877.90 on the basis of current market price and Tk. 1,256,582,683.88 on the basis of cost price after considering all assets and liabilities of the Fund.
ICBEPMF1S1: Weekly NAV
On the close of operation on 05-Nov-2024, the Fund has reported Net Asset Value (NAV) of Tk. 7.53 per unit on the basis of current market price and Tk. 12.42 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 564,512,205.86 on the basis of current market price and Tk. 931,728,677.60 on the basis of cost price after considering all assets and liabilities of the Fund.
ICBAMCL2ND: Weekly NAV
On the close of operation on 05-Nov-2024, the Fund has reported Net Asset Value (NAV) of Tk. 8.23 per unit on the basis of current market price and Tk. 13.84 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 411,395,827.65 on the basis of current market price and Tk. 692,246,321.77 on the basis of cost price after considering all assets and liabilities of the Fund.
1STPRIMFMF: Weekly NAV
On the close of operation on 05-Nov-2024, the Fund has reported Net Asset Value (NAV) of Tk. 9.01 per unit on the basis of current market price and Tk. 17.85 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 180,144,661.10 on the basis of current market price and Tk. 357,062,309.81 on the basis of cost price after considering all assets and liabilities of the Fund.
ITC: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
SONARGAON: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
VFSTDL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
APEXTANRY: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2024 at 6:45 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
PHARMAID: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
SONALIANSH: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2024 at 4:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
IBP: Reschedule of Board Meeting under LR 19(1)
The Company has further informed that, the Board meeting under LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on November 12, 2024 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
GENEXIL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2024 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
FORTUNE: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2024 at 5:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.